Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of IMMU-132 in HR+/HER2- MBC (TROPICS-02)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03901339
Recruitment Status : Recruiting
First Posted : April 3, 2019
Last Update Posted : March 5, 2021
Sponsor:
Information provided by (Responsible Party):
Immunomedics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2021
Estimated Study Completion Date : May 2023
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):